ConductScience.org, home

Paper847477

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.

Burt DR and 2 others. Science, 1977. Cited by 742 papers, by iCite.

Cite this record

ConductScience Library. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Papers, record 847477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/847477

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.
PubMed
Journal
Science
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
742
iCite
Relative citation ratio, by iCite
28
iCite
Revised in PubMed
2019-06-18
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Burt DRD R
2Creese II
3Snyder SHS H

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Corpus StriatumMajor topic
Receptors, DopamineMajor topic
Tranquilizing AgentsMajor topic
Animals
Apomorphine
Dextroamphetamine
Dose-Response Relationship, Drug
Fluphenazine
Haloperidol
Kinetics
Rats
Reserpine
Time Factors

Source PubMed

Download CSV of topics

Cited by158

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 742 citations.

PMIDTitleJournalYearIn PapersSource
41036601Morphological Changes in Direct Pathway Striatal Neurons in a Rat Model of Tardive Dyskinesia.Mov Disord2026https://conductscience.org/library/papers/41036601PubMed
39992373[Can antidepressants negatively alter the long-term course of depressive disorders?]Nervenarzt2025https://conductscience.org/library/papers/39992373PubMed
37907321Worsening stimulant use disorder outcomes coinciding with off-label antipsychotic prescribing: a commonly unrecognised side effect?BMJ Case Rep2023https://conductscience.org/library/papers/37907321PubMed
36979877Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal.Biomedicines2023https://conductscience.org/library/papers/36979877PubMed
36760795Enhancement of adenosine A2A signaling improves dopamine D2 receptor antagonist-induced dyskinesia via β-arrestin signaling.Front Neurosci2022https://conductscience.org/library/papers/36760795PubMed
36277907Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis.Front Neurol2022https://conductscience.org/library/papers/36277907PubMed
33550976Recent Discussions on Dopamine Supersensitivity Psychosis: Eight Points to Consider When Diagnosing Treatment-Resistant Schizophrenia.Curr Neuropharmacol2021https://conductscience.org/library/papers/33550976PubMed
32725283Effects of CATECHIN on reserpine-induced vacuous chewing movements: behavioral and biochemical analysis.Naunyn Schmiedebergs Arch Pharmacol2020https://conductscience.org/library/papers/32725283PubMed
30306450VMAT2 Inhibitors in Neuropsychiatric Disorders.CNS Drugs2018https://conductscience.org/library/papers/30306450PubMed
29856543What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?World Psychiatry2018https://conductscience.org/library/papers/29856543PubMed
29325847Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia.Biol Psychiatry2018https://conductscience.org/library/papers/29325847PubMed
28188355Repeated MDMA administration increases MDMA-produced locomotor activity and facilitates the acquisition of MDMA self-administration: role of dopamine D2 receptor mechanisms.Psychopharmacology (Berl)2017https://conductscience.org/library/papers/28188355PubMed
26833841An examination of sex differences in the effects of early-life opiate and alcohol exposure.Philos Trans R Soc Lond B Biol Sci2016https://conductscience.org/library/papers/26833841PubMed
26786412Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders.Psychopharmacology (Berl)2016https://conductscience.org/library/papers/26786412PubMed
25449842Striatal dopamine receptor plasticity in neurotensin deficient mice.Behav Brain Res2015https://conductscience.org/library/papers/25449842PubMed
24838395Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.Mov Disord2014https://conductscience.org/library/papers/24838395PubMed
24077804Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys.Psychopharmacology (Berl)2013https://conductscience.org/library/papers/24077804PubMed
23846543
Opposite effects of typical and atypical anti-psychotic drugs on sensitized dopamine receptors: sub-chronic low dose Olanzapine exposure reverses sensitization but a similar regimen of low dose haloperidol potentiates sensitization effects.
Psychopharmacology (Berl)2013https://conductscience.org/library/papers/23846543PubMed
23224422Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.Naunyn Schmiedebergs Arch Pharmacol2013https://conductscience.org/library/papers/23224422PubMed
22331262Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism.Naunyn Schmiedebergs Arch Pharmacol2012https://conductscience.org/library/papers/22331262PubMed

See all 158 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/847477

GET https://conductscience.org/api/papers/v1/847477/cited_by?page=2